BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02694523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: risankizumab
BIOLOGICAL: adalimumab
DRUG: placebo for risankizumab
BIOLOGICAL: placebo for adalimumab

Sponsor

AbbVie

Collaborators

[object Object]